Showing results (61-70 of 73) with videos related to
Sort By:
Pageof 8
The Journal of Extra-Corporeal Technology|February 6, 2023
A Systematic Review with Meta-Analysis Investigating the Impact of Targeted Perfusion Parameters during Extracorporeal Cardiopulmonary Resuscitation in Out-of-Hospital and Inhospital Cardiac ArrestLars Saemann, Sven Maier, Lisa Rösner, et al.Journal of Clinical Medicine|September 9, 2023
Impact of Age on Endothelial Function of Saphenous Vein Grafts in Coronary Artery Bypass GraftingLars Saemann, Lena Wernstedt, Sabine Pohl, et al.Biomedizinische Technik. Biomedical Engineering|January 27, 2026
Polymeric micro- and nanoparticle release from cardiopulmonary bypass and extracorporeal membrane oxygenation circuitsLars Saemann, Markus Stiller, Hardik Vaghasiya, et al.Journal of Molecular and Cellular Cardiology Plus|November 5, 2025
Age, sex, and vessel region affect the vasomotor function and gene expression signature of the aorta in miceLars Saemann, Lotta Hartrumpf, Adrian-Iustin Georgevici, et al.Herz|June 27, 2008
Methods to evaluate the pharmacology of oral antiplatelet drugsArtur-Aron Weber, Michael Adamzik, Hagen S Bachmann, et al.International Journal of Molecular Sciences|February 24, 2024
HTK vs. HTK-N for Coronary Endothelial Protection during Hypothermic, Oxygenated Perfusion of Hearts Donated after Circulatory DeathLars Saemann, Kristin Wächter, Nitin Gharpure, et al.The Journal of Allergy and Clinical Immunology|June 2, 2020
SARS-CoV-2 antibody testing-questions to be askedMustafa K Özçürümez, Andreas Ambrosch, Oliver Frey, et al.International Journal of Molecular Sciences|January 27, 2024
Transcriptomic Changes in the Myocardium and Coronary Artery of Donation after Circulatory Death Hearts following Ex Vivo Machine PerfusionLars Saemann, Kristin Wächter, Adrian-Iustin Georgevici, et al.Journal of Cardiovascular Translational Research|September 8, 2025
Cardioplegic Machine Perfusion of Hearts Donated after Circulatory DeathLars Saemann, Kristin Wächter, Anne Großkopf, et al.Marine Drugs|September 8, 2019
First Results from a Screening of 300 Naturally Occurring Compounds: 4,6-dibromo-2-(2',4'-dibromophenoxy)phenol, 4,5,6-tribromo-2-(2',4'-dibromophenoxy)phenol, and 5-epi-nakijinone Q as Substances with the Potential for Anticancer TherapySaskia Mayer, Marie Prechtl, Pia Liebfried, et al.Pageof 8